I. ERYILMAZ Et Al. , "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.," Neurological research , vol.39, pp.965-972, 2017
ERYILMAZ, I. Et Al. 2017. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.. Neurological research , vol.39 , 965-972.
ERYILMAZ, I., CECENER, G., ERER, S., EGELI, U., TUNCA, B., ZARIFOGLU, M., ... ELIBOL, B.(2017). Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.. Neurological research , vol.39, 965-972.
ERYILMAZ, DURUHAN Et Al. "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.," Neurological research , vol.39, 965-972, 2017
ERYILMAZ, DURUHAN M. Et Al. "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.." Neurological research , vol.39, pp.965-972, 2017
ERYILMAZ, I. Et Al. (2017) . "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.." Neurological research , vol.39, pp.965-972.
@article{article, author={DURUHAN MELTEM DEMİRKIRAN Et Al. }, title={Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.}, journal={Neurological research}, year=2017, pages={965-972} }